|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | C12N 5/00 | (2006.01) |
| (11) | Number of the document | 2563904 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11717240.3 |
| Date of filing the European patent application | 2011-04-25 | |
| (97) | Date of publication of the European application | 2013-03-06 |
| (45) | Date of publication and mention of the grant of the patent | 2015-01-21 |
| (46) | Date of publication of the claims translation | 2015-05-25 |
| (86) | Number | PCT/EP2011/056508 |
| Date | 2011-04-25 |
| (87) | Number | WO 2011/134920 |
| Date | 2011-11-03 |
| (30) | Number | Date | Country code |
| 327836 P | 2010-04-26 | US |
| (72) |
LEIST, Christian, CH
MEISSNER, Petra, CH
SCHMIDT, Jörg, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Pagerinta ląstelių mitybos terpė |
| IMPROVED CELL CULTURE MEDIUM |
| Payment date | Validity (years) | Amount | |
| 2023-04-06 | 13 | 289.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2021-09-01 |